How are stem cell products quality-checked?
Cell products are checked for identity, contamination and genetic stability. This guide explains the main tests and what each one is for.

Key takeaways.
- Living cells vary in ways small-molecule drugs do not, so cell products are harder to characterise.
- Flow cytometry is the gold standard for confirming MSC surface markers against the ISCT criteria.
- The LAL assay is the standard test for endotoxin, a bacterial contaminant.
- Karyotyping looks for chromosomal abnormalities that may indicate transformation risk.
- Genetic stability checks matter most at higher passage numbers during culture expansion.
- Quality testing describes the product. It does not make a therapy FDA-approved.
Why cell products are hard to characterise
A traditional drug has a precisely defined molecular structure. A cell product does not. Living cells vary in ways that small molecules never do, so consistent quality depends on testing at each step of manufacturing.
The main tests answer three questions. Are these the right cells? Is the product free of contamination? Are the cells genetically stable?
Identity: flow cytometry
Flow cytometry is the gold standard for confirming surface marker expression on mesenchymal stem/stromal cells (MSCs). It analyses thousands of cells individually and can read several markers at once. It is essential for verifying the ISCT minimal criteria, the identity standard for MSCs.
Safety: endotoxin and genetic stability
Endotoxin is bacterial lipopolysaccharide, a contaminant and a critical safety concern in cell therapy products. The standard detection method is the Limulus Amebocyte Lysate (LAL) assay, which uses components of horseshoe crab blood cells.
Karyotyping examines the chromosomes. It is performed to detect abnormalities that might indicate transformation risk. It is particularly important at higher passage numbers, because genetic stability must be maintained while cells are expanded in culture.
Storage and the limits of testing
Frozen products use DMSO as a cryoprotectant. It prevents ice crystals from forming and damaging cell membranes.
Quality testing tells you what is in the vial. It does not establish clinical benefit. Stem cell therapies are not FDA-approved for the orthopaedic, pain and aesthetic uses that clinics market.
Educational content for healthcare professionals. Not a treatment recommendation. Stem cell therapies are not FDA-approved for the orthopaedic, pain and aesthetic uses most clinics offer.
This guide covers the what and the why.
The how is taught live. The webinar and live training go deeper on:
- How to read a product's quality documentation
- Quality control across the manufacturing process
- Questions to ask a supplier about testing
- How quality data fits into product evaluation
Common questions.
How is MSC identity confirmed?
What does the LAL assay test for?
Why is karyotyping done on cultured MSCs?
Keep reading.
Stem cell · 3 min read
How does the FDA regulate stem cell products? Section 361 versus Section 351
The FDA sorts cell and tissue products into two categories, Section 361 and Section 351. Culture expansion usually puts an MSC product in the stricter one.
Start the lessonStem cell · 3 min read
How do published stem cell studies select patients?
Who is enrolled shapes what a stem cell study can show. This guide covers how published MSC research frames disease stage, phenotype and tissue type.
Start the lessonStem cell · 3 min read
What is a stem cell?
Stem cells are defined by two properties: self-renewal and the capacity to differentiate. Here is what that means and where clinical use stands.
Start the lessonReady for the hands-on detail?
Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.